Skip to main content
. 2022 Jul 12;10:795158. doi: 10.3389/fped.2022.795158

Table 1.

Characteristics of emergency admissions: survivors vs. non-survivors.

Characteristic N (%) Estimated differences
OR (95% CI)
p
All admissions
(n = 200)
Survivors
(n = 178)
Non-survivors
(n = 22)
Male gender 102 (51) 90 (50.6) 12 (54.5) 1.2 (0.4–3.2) 0.9
Age#, years 8.3 (3.1–14.7) 7.8 (3–8.4) 12.6 (4–15.3) 1.1 (0–0.1) 0.19
#PICU length of stay (days) 2.8 (1–7) 2 (1–5.8) 8.5 (4.3–26.5) 1.04 (0–0.1) 0.006
Severe neutropenia 62 (31) 49 (27.5) 13 (59) 3.8 (1.4–10.7) 0.006
Readmittance 118 (59) 104 (58.4) 14 (63.3) 1.2 (0.5–3.6) 0.82
MODS present 36 (18) 18 (10.1) 18 (81.8) 38.3 (11.1–173.1) <0.001
Diagnoses
Leukemia 76 (38) 65 (36.5) 11 (50) 1.7 (0.6–4.7) 0.32
Lymphoma 29 (14.5) 25 (14) 4 1.4 (0.3–4.6) 0.53
Brain/spinal cord 31 (15.5) 27 (15.2) 4 1.2 (0.3–4.2) 0.76
Solid 28 (14) 28 (15.7) 0 0 (0–1.1) 0.05
Hematological 36 (18) 33 (18.5) 3 0.7 (0.1–2.6) 0.77
Transplant history
Autologous HSCT 15 (7.5) 14 (7.9) 1 0.6 (0–4.1) 1
Allogeneic hSCT 56 (28) 45 (25.3) 11 (50) 2.9 (1.1–8.1) 0.022
SOT 8 (4) 8 (4.5) 0 0 (0–4.9) 0.6
None 121 (60.5) 111 (62.4) 10 (45.5) 0.5 (0.2–1.4) 0.165
PICU treatment
IMV 69 (34.5) 49 (27.5) 20 (90.1) 25.9 (5.9–235.5) <0.001
IMV >2 days 46 (23) 29 (16.3) 17 (77.3) 17.1 (5.5–64.1) <0.001
CRRT 18 (9) 11 (6.2) 7 (31.8) 6.8 (0.9–43.3) 0.03
ECMO 7 (3.5) 4 3 7 (2–23.4) 0.001
Inotropic support 43 (21.5) 28 (15.7) 15 (68.2) 11.3 (3.9–35.9) <0.001
VIS# 0 (0–0) 0 (0–0) 22 (0–43.9) 1.1 (0.1–0.2) <0.001
#

Median [interquartile range (IQR)]; PICU, pediatric intensive care unit;

at admission; MODS, multiple organ dysfunction syndrome; HSCT, hematopoietic stem cell transplantation; SOT, solid organ transplantation; IMV, invasive mechanical ventilation; CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation; VIS, vasoactive ionotropic score; OR, odds ratio; CI, confidence interval. Bold values denote statistically significant.